Moderna will supply COVAX with up to 500 million doses of its coronavirus vaccine from the end of the year, the US drugmaker said on Monday, just as Sweden has pledged to send 1 million doses through the vaccine sharing mechanism.
As part of the deal, Moderna will work with Gavi, the Vaccine Alliance, to deliver 34 million doses to COVAX – a mechanism established with the World Health Organization and the Coalition for Epidemic Preparedness Innovations (CEPI) to deliver vaccines for low- and middle-income countries. – end of 2021.
The vaccines will be offered at Moderna’s “lowest price” and Gavi will be able to purchase an additional 466 million doses in 2022.
“We recognize that many countries have limited resources to access COVID-19 vaccines,” Moderna CEO Stéphane Bancel wrote in a press release. “We support COVAX’s mission to ensure broad, affordable and equitable access to COVID-19 vaccines and we remain committed to doing all we can to end this ongoing pandemic with our COVID-19 mRNA vaccine. “
WHO listed Moderna’s coronavirus vaccine for emergency use late last week, paving the way for four vaccines for use globally through COVAX. WHO has already added BioNTech / Pfizer, two vaccine makers Oxford / AstraZeneca and Johnson & Johnson to its emergency use list.
However, COVAX had delivered only a fraction of the vaccines it had planned to deliver by May, as large, rich countries bought most of the available doses. In addition, the Serum Institute of India, which was supposed to produce many Oxford / AstraZeneca doses of COVAX, was unable to export due to India’s temporary ban on vaccine exports.
COVAX is in “urgent” need of 20 million doses in the second quarter of this year after strong demand for doses in India caused “interruptions” in supply, the WHO wrote in a press release.
Sweden on Monday unveiled plans to send 1 million doses of Oxford / AstraZeneca through the vaccine-sharing mechanism to “help address short-term supply delays,” according to a press release from Gavi. The doses are already fully paid for and will allow high-risk groups such as healthcare workers to receive their second injection.
“Such support will ensure that people living in vulnerable countries, especially in Africa, can receive their second dose through the COVAX initiative,” WHO Director-General Tedros Adhanom Ghebreyesus wrote in a statement. “Sweden’s generous support is very timely as it comes at a time when the world needs it most.”
To date, France has sent around 100,000 doses of Oxford / AstraZeneca to Mauritania out of the 500,000 promised via COVAX.
Ashleigh Furlong contributed reporting.
The story has been updated.
This article is part of POLITICOPremium Police Service from: Pro Health Care. Whether it’s the prices of medicines, EMAs, vaccines, pharmaceuticals and more, our specialist journalists keep you up to date on the topics driving the health policy agenda. E-mail [email protected] for a free trial.